4.7 Article

Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors

Journal

ANNALS OF SURGICAL ONCOLOGY
Volume 23, Issue 13, Pages 4277-4283

Publisher

SPRINGER
DOI: 10.1245/s10434-016-5411-0

Keywords

-

Funding

  1. French Research Network on Kidney Cancer UroCCR

Ask authors/readers for more resources

Only a few studies have compared the outcomes of robotic partial nephrectomy (RPN) and open partial nephrectomy (OPN). This study aimed to compare perioperative and oncologic outcomes of RPN and OPN. The data of all patients who underwent partial nephrectomy from 2006 to 2014 in six academic departments of urology were retrospectively collected. Perioperative outcomes were compared between OPN and RPN patients. Cancer-specific survival (CSS) and recurrence-free survival (RFS) were estimated using the Kaplan-Meier method and compared using the log-rank test. The study included 1800 patients: 937 who underwent RPN and 863 who underwent OPN. The patients in the robotic group had smaller tumors (33.1 vs. 39.9 mm; p < 0.001) but comparable RENAL scores (6.8 vs. 6.7; p = 0.37). The complication rate was higher in the OPN group (28.6 vs. 18 %; p < 0.001). The OPN patients had greater estimated blood loss (359.5 vs. 275 ml; p < 0.001) and more frequent hemorrhagic complications (12.1 vs. 6.9 %; p < 0.001). The robotic approach was associated with a shorter warm ischemia time (WIT 15.7 vs. 18.6 min; p < 0.001) and a shorter hospital of stay (4.7 vs. 10.1 days; p < 0.001). In the propensity score-weighted analysis, the inverse probability of treatment weighting adjusted odds ratio for the risk of complication after OPN versus RPN was 2.11 (95 % confidence interval, 1.53-2.91; p < 0.001). After a median postoperative follow-up period of 13 months for OPN and 39 months for RPN (p < 0.001), CSS and RFS were similar in the two groups. In the multivariate analysis, RPN showed an impact on the occurrence of a complication but had no effect on WIT or RFS. In this study, RPN was less morbid than OPN, with lower complications, less blood loss, and a shorter hospital of stay. The intermediate-term oncologic outcomes were similar in the two groups.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

Evaluation of oncological outcomes of robotic partial nephrectomy according to the type of hilar control approach (On-clamp vs Off-clamp), a multicentric study of the French network of research on kidney cancer-UROCCR 58-NCT03293563

Adil Mellouki, Imad Bentellis, Arnoult Morrone, Nicolas Doumerc, Jean-Baptiste Beauval, Morgane Roupret, Francois-Xavier Nouhaud, Cedric Lebacle, Jean-Alexandre Long, Daniel Chevallier, Brannwel Tibi, Aysha Shaikh, L. Imbert de la Phalecque, Pierre Pillot, Xavier Tillou, Jean-Christophe Bernhard, Matthieu Durand, Youness Ahallal

Summary: This study compared the oncological outcomes of off-clamp and on-clamp robotic partial nephrectomy for renal cell carcinoma and found that the hilar control approach did not have a significant impact on positive surgical margin rate or survival outcomes. Age at surgery was found to be an independent factor affecting positive surgical margin.

WORLD JOURNAL OF UROLOGY (2023)

Article Urology & Nephrology

Predictive factors of recurrence after surgery in patients with non-metastatic renal cell carcinoma with venous tumor thrombus (UroCCR-56 Study)

Michael Baboudjian, Bastien Gondran-Tellier, Zineddine Khene, Pierre Bigot, Arnaud Mejean, Herve Lang, Cedric Lebacle, Nicolas Doumerc, Franck Bruyere, Francois-Xavier Nouhaud, Idir Ouzaid, Karim Bensalah, Jean Christophe Bernhard, Romain Boissier

Summary: This study assessed the oncological outcomes of renal cell carcinoma (RCC) with tumor thrombus and identified predictive factors of recurrence. The results showed that adjuvant therapy was effective in reducing cancer recurrence risk.

WORLD JOURNAL OF UROLOGY (2023)

Article Urology & Nephrology

3D-Image guided robotic-assisted partial nephrectomy: a multi-institutional propensity score-matched analysis (UroCCR study 51)

Clement Michiels, Zine-Eddine Khene, Thomas Prudhomme, Astrid Boulenger de Hauteclocque, Francois H. Cornelis, Melanie Percot, Helene Simeon, Laure Dupitout, Henri Bensadoun, Gregoire Capon, Eric Alezra, Vincent Estrade, Franck Bladou, Gregoire Robert, Jean-Marie Ferriere, Nicolas Grenier, Nicolas Doumerc, Karim Bensalah, Jean-Christophe Bernhard

Summary: In robot-assisted partial nephrectomy (RAPN), using three-dimensional model reconstructions for preoperative planning and intraoperative guidance can reduce complications and improve perioperative clinical outcomes.

WORLD JOURNAL OF UROLOGY (2023)

Review Urology & Nephrology

Role of pelvic drain and timing of urethral catheter removal following RARP: a systematic review and meta-analysis

Takafumi Yanagisawa, Tatsushi Kawada, Hadi Mostafaei, Reza Sari Motlagh, Fahad Quhal, Ekaterina Laukhtina, Pawel Rajwa, Markus von Deimling, Alberto Bianchi, Maximilian Pallauf, Benjamin Pradere, Pierre I. Karakiewicz, Jun Miki, Takahiro Kimura, Shahrokh F. Shariat

Summary: This study aimed to assess the clinical value of routine pelvic drain (PD) placement and early removal of urethral catheter (UC) in patients undergoing robot-assisted radical prostatectomy (RARP). The results showed that routine PD placement has no benefit and early removal of UC may increase the risk of urinary retention.

BJU INTERNATIONAL (2023)

Editorial Material Urology & Nephrology

Pregnancy and Urology Residency: Towards Equity-centred Practice

Laura S. Mertens, Geraldine Pignot, Luca Afferi, Juan Luis Vasquez, Carmen Mir, Benjamin Pradere

EUROPEAN UROLOGY (2023)

Review Oncology

Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence

Mara Bacchiani, Vincenzo Salamone, Eleana Massaro, Alessandro Sandulli, Riccardo Mariottini, Anna Cadenar, Fabrizio Di Maida, Benjamin S. Pradere, Laura Mertens, Mattia Longoni, Wojciech Krajewski, Francesco Del Giudice, David D'Andrea, Ekaterina F. Laukhtina, Shahrokh Shariat, Andrea Minervini, Marco Moschini, Andrea Mari

Summary: Lymph node involvement is an essential factor for bladder cancer prognosis. 18F-FDG PET/CT has been increasingly used for accurate staging and post-treatment restaging. This literature review summarizes the evidence on its sensitivity and specificity for detecting LN metastasis in bladder cancer, aiming to provide clinicians with a better understanding of its potential benefits and limitations in clinical practice.

CANCERS (2023)

Review Oncology

Efficacy of Different Bacillus of Calmette-Guerin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis

Francesco Del Giudice, Vincenzo Asero, Eugenio Bologna, Carlo Maria Scornajenghi, Dalila Carino, Virginia Dolci, Pietro Viscuso, Stefano Salciccia, Alessandro Sciarra, David D'Andrea, Benjamin Pradere, Marco Moschini, Andrea Mari, Simone Albisinni, Wojciech Krajewski, Tomasz Szydelko, Bartosz Malkiewicz, Lukasz Nowak, Ekaterina Laukhtina, Andrea Gallioli, Laura S. Mertens, Gautier Marcq, Alessia Cimadamore, Luca Afferi, Francesco Soria, Keiichiro Mori, Karl Heinrich Tully, Renate Pichler, Matteo Ferro, Octavian Sabin Tataru, Riccardo Autorino, Simone Crivellaro, Felice Crocetto, Gian Maria Busetto, Satvir Basran, Michael L. Eisenberg, Benjamin Inbeh Chung, Ettore De Berardinis

Summary: In this systematic review and meta-analysis, the cumulative bladder cancer (BC) recurrence rates and efficacy profile of different Bacillus of Calmette-Guerin (BCG) strains were compared. The study found that BCG Tokyo 172 had the lowest recurrence rate among studies with <= 3-year recurrence-free survival (RFS). No significant difference was observed among strains in >3-year RFS outcomes. The genetically different BCG strains RIVM, Tice, and Tokyo 172 showed some potential enhanced benefits.

CANCERS (2023)

Article Oncology

Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis

Nico C. Grossmann, Francesco Soria, Tristan Juvet, Aaron M. Potretzke, Hooman Djaladat, Alireza Ghoreifi, Eiji Kikuchi, Andrea Mari, Zine-Eddine Khene, Kazutoshi Fujita, Jay D. Raman, Alberto Breda, Matteo Fontana, John P. Sfakianos, John L. Pfail, Ekaterina Laukhtina, Pawel Rajwa, Maximillian Pallauf, Cedric Poyet, Giovanni E. Cacciamani, Thomas van Doeveren, Joost L. Boormans, Alessandro Antonelli, Marcus Jamil, Firas Abdollah, Guillaume Ploussard, Axel Heidenreich, Enno Storz, Siamak Daneshmand, Stephen A. Boorjian, Morgan Roupret, Michael Rink, Shahrokh F. Shariat, Benjamin Pradere

Summary: The study compared perioperative and oncologic outcomes among patients who underwent open, laparoscopic, and robotic RNU for non-metastatic upper urinary tract urothelial carcinoma. The results showed worse bladder recurrence-free survival in patients who had laparoscopic and robotic RNU compared to open RNU. However, recurrence-free, cancer-specific, and overall survival were similar between the three surgical approaches. Laparoscopic and robotic RNU were associated with shorter hospital stay and fewer major postoperative complications. Further research is needed to investigate the factors responsible for the inferior bladder recurrence-free survival in patients treated with minimally invasive techniques.

CANCERS (2023)

Article Immunology

Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis

Takafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, Kensuke Bekku, Ekaterina Laukhtina, Pawel Rajwa, Markus von Deimling, Marcin Chlosta, Benjamin Pradere, Pierre Karakiewicz, Keiichiro Mori, Takahiro Kimura, Manuela Schmidinger, Shahrokh F. Shariat

Summary: This study aimed to compare the effectiveness of first-line immune checkpoint inhibitor (ICI)-based combinations in metastatic renal cell carcinoma (mRCC) patients, stratified by age. The results showed that ICI-based combinations improved overall survival (OS) in both younger and older patients, with more pronounced benefits in younger patients.

IMMUNOTHERAPY (2023)

Article Urology & Nephrology

5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (& alpha;-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data

Francesco Del Giudice, Federico Belladelli, Frank Glover, Satvir Basran, Shufeng Li, Evan Mulloy, Benjamin Pradere, Francesco Soria, Wojciech Krajewski, Rajesh Nair, Wade Muncey, Nicolas Seranio, Michael L. Eisenberg

Summary: No protective effect of 5-alpha reductase inhibitors (5-ARi) on bladder cancer (BCa) risk in men with Benign Prostatic Hyperplasia (BPH) was found based on a large US database study. The use of 5-ARi did not change the risk of new BCa in men.

WORLD JOURNAL OF UROLOGY (2023)

Meeting Abstract Urology & Nephrology

THE ROLE OF EXTENDED VERSUS STANDARD LYMPHADENECTOMY LYMPH NODE DISSECTION IN CLINICALLY LYMPH NODE-POSITIVE BLADDER CANCER

Markus Von Deimling, Andrea Mari, Alberto Bianchi, Moritz Maas, Renate Pichler, Malte W. Vetterlein, Francesco Del Giudice, Karl H. Tully, Luca Afferi, Marco Moschini, Ekaterina Laukhtina, Michael Rink, Shahrokh F. Shariat, Benjamin Pradere

JOURNAL OF UROLOGY (2023)

Meeting Abstract Urology & Nephrology

Carboplatin induction chemotherapy in clinically lymph node-positive bladder cancer

M. von Deimling, L. S. Mertens, B. W. G. Van Rhijn, Y. Lotan, P. E. Spiess, S. Daneshmand, P. C. Black, M. Pallauf, D. D'Andrea, M. Moschini, F. Soria, F. Del Giudice, L. Afferi, E. Laukhtina, T. Yanagisawa, T. Kawada, J. Y. C. Teoh, G. Ploussard, M. Roumiguie, P. Karakiewicz, P. Gontero, M. Rink, S. F. Shariat, B. Pradere

EUROPEAN UROLOGY (2023)

Meeting Abstract Urology & Nephrology

Impact of gender on the efficacy of immune checkpoint inhibitors for urological cancers: A systematic review and meta-analysis

T. Yanagiswawa, T. Kawada, F. Quhal, K. Bekku, E. Laukhtina, P. Rajwa, M. Von Deimling, M. Majdoub, M. Chlosta, B. Pradere, K. Mori, T. Kimura, M. Schmidinger, S. F. Shariat

EUROPEAN UROLOGY (2023)

Article Urology & Nephrology

Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guerin: Implications for Decision-making?

Francesco Soria, David D'Andrea, Maurizio Barale, Kilian M. Gust, Francesca Pisano, Simone Mazzoli, Matteo De Bellis, Matteo Rosazza, Simone Livoti, Daniele Dutto, Beatrice Lillaz, Benjamin Pradere, Marco Moschini, Dietmar Tamandl, Shahrokh F. Shariat, Paolo Gontero

Summary: This study investigates the predictive and prognostic role of sarcopenia in patients with high-grade non-muscle invasive bladder cancer. The study found that sarcopenia is associated with disease recurrence and progression and can improve the predictive ability of existing models. Therefore, sarcopenia can be used as a marker to guide treatment and follow-up.

EUROPEAN UROLOGY OPEN SCIENCE (2023)

Article Urology & Nephrology

Partial nephrectomy in solitary kidneys: comparison between open surgery and robotic-assisted laparoscopy on perioperative and functional outcomes (UroCCR-54 study)

Ygal Benichou, Francois Audenet, Karim Bensalah, Morgan Roupret, Philippe Paparel, Cedric Lebacle, Franck Bruyere, Jean-Baptiste Beauval, Arnauld Villers, Herve Lang, Xavier Durand, Pierre Bigot, Jean Alexandre Long, Cecile Champy, Alexandre Lavolle, Jean Christophe Bernhard, Eric Alezra

Summary: This study compared the perioperative results of robotic-assisted partial nephrectomy (RAPN) to open surgery in patients with solitary kidney tumors. The study found that there was no significant difference between the two groups in terms of eGFR variation and Trifecta success, but the RAPN group had significantly shorter hospital stay and fewer complications compared to the open surgery group.

WORLD JOURNAL OF UROLOGY (2023)

No Data Available